Dongwha Pharm.Co.,Ltd (KRX:000020)

Market Cap	173.24B
Revenue (ttm)	481.53B
Net Income (ttm)	6.33B
Shares Out	27.72M
EPS (ttm)	228.28
PE Ratio	27.38
Forward PE	n/a
Dividend	180.00 (2.88%)
Ex-Dividend Date	Dec 27, 2024

Volume	97,085
Average Volume	65,281
Open	6,280.00
Previous Close	6,260.00
Day's Range	6,110.00 - 6,280.00
52-Week Range	5,600.00 - 7,530.00
Beta	0.35
RSI	45.33
Earnings Date	Nov 13, 2025

About Dongwha Pharm.Co.,Ltd

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health su...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 812
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000020

Financial Performance

In 2024, Dongwha Pharm.Co.,Ltd's revenue was 464.87 billion, an increase of 28.74% compared to the previous year's 361.11 billion. Earnings were 5.56 billion, a decrease of -79.72%.